Clinical value of Furosemide intervention on PET/CT imaging for detecting recurrence and#br#
metastasis of cervical cancer

HU Xiao-yan; PENG Liao-he; LI Lei; NI Yin; LI Jie; ZHU Jia; QIU Da-sheng; DING Jiu-rong; ZHOU Jing

doi:10.12117/jccmi.2018.09.018

Journal of China Clinic Medical Imaging ›› 2018, Vol. 29 ›› Issue (9) : 672-675. DOI: 10.12117/jccmi.2018.09.018

Clinical value of Furosemide intervention on PET/CT imaging for detecting recurrence and#br# metastasis of cervical cancer

HU Xiao-yan, PENG Liao-he, LI Lei, NI Yin, LI Jie, ZHU Jia, QIU Da-sheng, DING Jiu-rong, ZHOU Jing

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

HU Xiao-yan, PENG Liao-he, LI Lei, NI Yin, LI Jie, ZHU Jia, QIU Da-sheng, DING Jiu-rong, ZHOU Jing. Clinical value of Furosemide intervention on PET/CT imaging for detecting recurrence and#br# metastasis of cervical cancer[J]. Journal of China Clinic Medical Imaging. 2018, 29(9): 672-675 https://doi.org/10.12117/jccmi.2018.09.018

References

[1]Benedet JL, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri[J]. J Epidemiol Biostat, 2001, 6: 7-43.
[2]Hong JH, Tsai CS, Lai CH, et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2004, 60: 249-257.
[3]吴湖炳，王全师，王明芳，等. 呋塞米介入试验在泌尿生殖系统肿瘤18F-FDG PET/CT显像中的应用[J]. 中华核医学杂志，2005，25（4）：206-208.
[4]Disaia PJ, Creasman WT. Clinical Gynecologic Oncology[M]. 6th ed. St Louis: Mothy Inc, 2002: 53-80.
[5]Oh D, Lee JE, Huh SJ, et al. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer[J]． Int J Radiat Oncol Biol Phys, 2013, 87(3): 549-554．
[6]Sharma P, Kumar R, Singh H, et al. Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging[J]. Nucl Med Commun, 2012, 33(2): 185-190.
[7]Onal C, Reyhan M, Guler OC, et al. Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy[J]. Eur J Nucl Med Mol Imaging, 2014, 41(7): 1336-1342.
[8]王全师. 18F-FDG PET/CT在宫颈癌中的临床价值[J]. 中华核医学杂志，2015，35（3）：161-163.
[9]Verswijvel GA, Oyen RH, Van Poppel HP, et al． Magnetic resonance imaging in the assessment of urologic disease: an all-in-one approach[J]. Eur Radiol, 2000, 10(10): 1614-1619.
[10]Lemes HP, Araujo S, Nascimento D, et al. Use of small doses of furosemide in chronic kidney disease patients with residual renal function under going hemodialysis[J]. Clin Exp Nephrol, 2011, 15(4): 554-559.
[11]Szopinski K, Szopinska M, Borowka A, et al. Magnetic resonance urography: initial experience of a low-dose Gd-DTPA-enhanced technique[J]. Eur Radiol, 2000, 10(7): 1158-1164.
[12]周文兰，吴湖炳，王全师，等. 18F-FDG PET/CT在宫颈癌诊断中的应用[J]. 中华核医学杂志，2008，28（3）：178-181.
[13]胡莹莹，张旭，樊卫，等. 18F-FDG PET/CT对可疑复发性宫颈癌的临床价值[J]. 中华核医学杂志，2011，31（2）：73-76.